Platform
Features
0 followers
Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions
Industries
Headquarters
Employees
Links
Dominick Colangelo
31 members
15 members
12 members
9 members
8 members
View all
This company has no offices yet
Active Motif
3 followers
Generation Bio
2 followers
Vaxart
Fortis Life Sciences
1 follower
Solugen
CHDI Foundation
5 followers
Cerapedics
Affinia Therapeutics
Helix
9 followers
Thermo Fisher Scientific
173 followers
Gilead Sciences
133 followers
Explore companies